Join us as we dissect SentinelOne's stock performance and future potential in the competitive cybersecurity landscape. Can ...

Revenue declined 9.4% year over year, impacted by reduced advertising and customer experience disruptions tied to the ...

Clinical Outcomes -- Twelve-month study data for the Catamaran implant showed VAS scores decreased from 78.8 to 23, and ODI ...

Research and development expense in fiscal Q3 2025 -- $4.5 million versus $4.9 million in fiscal Q3 2024. Net loss -- $5.9 ...

In Jim Cramer's "Stop Trading" segment on CNBC's Squawk on the Street program, the famous stock picker mentioned Amgen ...

Picky market players weren't impressed by the company's twin beats in its latest reported quarter.

Rule of 30 to 40 Trajectory -- Management expects the combined company could approach the sum of revenue growth rate plus ...

Florida Expansion -- Delegated capitation agreement with Elevance Health expanded in Q4 to include additional Medicare ...

Circle Internet Group now trades at a market cap of $19 billion. If you are a believer in the growth of stablecoins, now ...

And good afternoon, and welcome everyone to the Relmada Therapeutics, Inc. Third Quarter 2025 Conference Call. 2025 is ...

FDA Alignment -- BioAtla ( BCAB 4.08%) achieved FDA alignment on phase three trial design, dosing, comparator, and endpoints ...

Thursday, November 13, 2025 at 5 p.m. ET Need a quote from a Motley Fool analyst? Email [email protected] Net loss attributed to ...